Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€0.34
12.02.24
-
12.02.25
-25.69%
02.05.24

StockNews.com 
12.02.24 50%
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€0.94
12.02.24
€3.71
12.02.25
65.21%
03.05.24

HC Wainwright 
12.02.24 50%
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€3.80
10.02.24
€5.00
10.02.25
-46.90%
02.05.24

Could be worthwhile Investment >10% per year
melinda 
10.02.24 20%
sell
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€0.30
04.02.24
-
04.02.25
59.77%
02.05.24

StockNews.com 
04.02.24 50%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€1.05
03.02.24
-
03.02.25
1.90%
17.02.24

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
03.02.24 0%
sell
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€0.60
27.01.24
-
27.01.25
-57.65%
02.05.24

StockNews.com 
27.01.24 50%
buy
Lightpath Techs A

Start price
Target price
Perf. (%)
€1.20
18.01.24
€2.76
18.01.25
7.50%
02.05.24

Lake Street Capital 
18.01.24 50%
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.45
15.01.24
€1.00
15.07.24
-39.76%
03.05.24

Could be very worthwhile Investment >20% year
Andal66 
15.01.24 100%
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€4.89
30.12.23
€5.50
30.12.24
-22.39%
10.02.24

Could be worthwhile Investment >10% per year
melinda 
30.12.23 20%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€1.06
26.12.23
-
26.12.24
-8.96%
11.01.24

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
26.12.23 0%
sell
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€0.65
26.12.23
-
26.12.24
-25.61%
02.05.24

StockNews.com 
26.12.23 50%
sell
BioLase Inc.

Start price
Target price
Perf. (%)
€0.067
22.12.23
-
22.12.24
-
14.06.23

StockNews.com 
22.12.23 50%
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€0.67
21.12.23
-
21.12.24
131.22%
03.05.24

Cantor Fitzgerald 
21.12.23 50%
sell
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€0.68
10.12.23
-
10.12.24
-62.30%
02.05.24

StockNews.com 
10.12.23 50%
sell
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.23
05.12.23
-
05.12.24
165.45%
03.05.24

Lucius 
05.12.23 0%
sell
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€0.68
02.12.23
-
02.12.24
-28.56%
02.05.24

StockNews.com 
02.12.23 50%
sell
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.10
27.11.23
-
27.11.24
6.57%
09.12.23

Akuma 
27.11.23 0%
sell
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€0.58
24.11.23
-
24.11.24
-56.20%
02.05.24

StockNews.com 
24.11.23 50%
buy
My Size Inc

Start price
Target price
Perf. (%)
€0.25
21.11.23
€1.37
21.11.24
-
19.11.19

HC Wainwright 
21.11.23 50%
buy
Rewalk Robotics Ltd.

Start price
Target price
Perf. (%)
€0.67
15.11.23
€2.76
15.11.24
606.72%
12.04.24

HC Wainwright 
15.11.23 50%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€0.99
11.11.23
-
11.11.24
-
11.11.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
11.11.23 0%
buy
Electrocore Inc.

Start price
Target price
Perf. (%)
€0.26
09.11.23
€10.27
09.11.24
-
09.06.23

HC Wainwright 
09.11.23 50%
buy
Fulgent Genetics Inc

Start price
Target price
Perf. (%)
€24.75
06.11.23
€29.00
27.02.24
-5.66%
18.02.24

RudolfL 
06.11.23 50%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€0.81
05.11.23
-
05.11.24
15.43%
11.11.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
05.11.23 0%
buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.25
02.11.23
€0.50
02.11.24
-32.45%
02.05.24

Could be worthwhile Investment >10% per year
melinda 
02.11.23 20%